Filing Details

Accession Number:
0001493152-17-011518
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-10-11 18:26:30
Reporting Period:
2017-10-10
Accepted Time:
2017-10-11 18:26:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
883975 Microbot Medical Inc. MBOT Biological Products, (No Disgnostic Substances) (2836) 943078125
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1690100 Yoseph Bornstein C/O Microbot Medical Inc.
25 Recreation Park Drive, Unit 108
Hingham MA 02043
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-10-10 25,000 $1.37 5,020,409 No 4 S Indirect By LSA- LifeScience Accelerator Ltd.
Common Stock Disposition 2017-10-10 25,000 $1.39 5,020,409 No 4 S Indirect By LSA- LifeScience Accelerator Ltd. (2
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By LSA- LifeScience Accelerator Ltd.
No 4 S Indirect By LSA- LifeScience Accelerator Ltd. (2
Footnotes
  1. Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 50,000 shares of Issuer common stock on October 10, 2017. Accordingly, Reporting Person beneficially owned 5,020,409 shares of Issuer common stock following the reported transactions.
  2. Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. ("LSA") and of Shizim Ltd. ("Shizim"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities.